Vivani Medical, Inc.
VANI
$-0.01
Change (1 day)
$7.80
Year High
$0.84
Year Low
Categories
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
P/B ratio for Vivani Medical, Inc. (VANI)
P/B ratio as of 2023: 2.50
According to Vivani Medical, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.50. At the end of 2022 the company had a P/B ratio of 0.73.
P/B ratio history for Vivani Medical, Inc. from 2012 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | 2.50 |
| 2022 | 0.73 |
| 2021 | 21.88 |
| 2020 | 19.73 |
| 2019 | 12.00 |
| 2018 | 19.06 |
| 2017 | 13.12 |
| 2016 | 6.99 |
| 2015 | 10.36 |
| 2014 | 24.28 |
| 2013 | -245.19 |
| 2012 | -742.79 |